Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hoppe

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapyKristy Smith, Gracie Byer, Christopher G Morris, et al.
Acta Oncologica (Stockholm, Sweden)|September 1, 2016
Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group RegistryBradford S Hoppe, Henry Tsai, Gary Larson, et al.
Nature|September 14, 2019
Publisher Correction: Asymmetric lysosome inheritance predicts activation of haematopoietic stem cellsDirk Loeffler, Arne Wehling, Florin Schneiter, et al.
Nature|September 6, 2019
Asymmetric lysosome inheritance predicts activation of haematopoietic stem cellsDirk Loeffler, Arne Wehling, Florin Schneiter, et al.
Acta Oncologica (Stockholm, Sweden)|December 30, 2021
Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2012
Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphomaBradford S Hoppe, Stella Flampouri, Zhong Su, et al.
Oncogene|September 6, 2006
Basement membrane component laminin-5 is a target of the tumor suppressor Smad4M Zapatka, D Zboralski, Y Radacz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for UniformityAnish A Butala, Christina C Huang, Curtis M Bryant, et al.
Pediatric Blood & Cancer|May 6, 2016
Proton Therapy for Pediatric Hodgkin LymphomaJustin Wray, Stella Flampouri, William Slayton, et al.
Thoracic Cancer|June 23, 2019
Radiation-induced tumor immunity in patients with non-small cell lung cancerNatalie A Lockney, Mei Zhang, Christopher G Morris, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapyKristy Smith, Gracie Byer, Christopher G Morris, et al.
Acta Oncologica (Stockholm, Sweden)|September 1, 2016
Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group RegistryBradford S Hoppe, Henry Tsai, Gary Larson, et al.
Nature|September 14, 2019
Publisher Correction: Asymmetric lysosome inheritance predicts activation of haematopoietic stem cellsDirk Loeffler, Arne Wehling, Florin Schneiter, et al.
Nature|September 6, 2019
Asymmetric lysosome inheritance predicts activation of haematopoietic stem cellsDirk Loeffler, Arne Wehling, Florin Schneiter, et al.
Acta Oncologica (Stockholm, Sweden)|December 30, 2021
Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2012
Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphomaBradford S Hoppe, Stella Flampouri, Zhong Su, et al.
Oncogene|September 6, 2006
Basement membrane component laminin-5 is a target of the tumor suppressor Smad4M Zapatka, D Zboralski, Y Radacz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for UniformityAnish A Butala, Christina C Huang, Curtis M Bryant, et al.
Pediatric Blood & Cancer|May 6, 2016
Proton Therapy for Pediatric Hodgkin LymphomaJustin Wray, Stella Flampouri, William Slayton, et al.
Thoracic Cancer|June 23, 2019
Radiation-induced tumor immunity in patients with non-small cell lung cancerNatalie A Lockney, Mei Zhang, Christopher G Morris, et al.
Pageof 29